David C. Mohr, PhD
Director, Northwestern University’s Center for Behavioral Intervention Technologies; Professor, Department of Preventive Medicine, Feinberg School of Medicine
David C. Mohr, Ph.D. is a professor in the Northwestern University Feinberg School of Medicine’s Departments of Preventive Medicine, Psychiatry, and Medical Social Sciences. He is the Director of Northwestern University’s Center for Behavioral Intervention Technologies (CBITs; cbits.northwestern.edu) and Deputy Director of the Center for Engineering and Health.
Dr. Mohr, trained as a clinical psychologist, has long been interested in telehealth and telemental health. I recent years, his work has been at the intersection of behavioral science, technology, and clinical intervention research, and has focused on developing, optimizing, and evaluating interventions that harness web-based and wireless technologies to promote health and mental health. His current work in development includes the following projects: 1) the development a context sensing mobile application that harnesses indwelling sensor data within the phone to identify specific physical, social and emotional patient states and to integrate this system into mobile interventions; 2) the integration of web-based intervention and peer networking tools that use principles of online collaborative learning and supportive accountability to enhance learning and adherence; 3) the development of conversational agents (virtual humans) that can be used in web-based interventions to support interpersonal skills-training components of depression treatment programs, 4) evaluation of a stepped care treatment model integrating web-based care and telephone psychotherapy for the treatment of depression in primary care, and 5) the creation of a mobile intervention that monitors adherence to medications, provides just-in-time reminders, monitors response and side effects, and provides aggregated, actionable information to prescribing physicians. This later adherence system will be tested in patients receiving pharmacotherapies for depression and HIV, with a somewhat simpler version for patients with schizophrenia. Dr. Mohr is also interested in developing new methodologies for the evaluation of psychological and behavioral interventions that address the unique needs and rapidly changing technological environment of behavioral intervention technologies.